R01 DK102815/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2016	4
2017	2
2018	1
2019	3
2020	2
2021	1
2022	2
2023	5
2024	1

1

Overview of iron metabolism in health and disease.

Dev S, Babitt JL. Dev S, et al. Hemodial Int. 2017 Jun;21 Suppl 1(Suppl 1):S6-S20. doi: 10.1111/hdi.12542. Epub 2017 Mar 15. Hemodial Int. 2017. PMID: 28296010 Free PMC article. Review.

2

Transcriptomics: a Solution for Renal Osteodystrophy?

Martin A, David V. Martin A, et al. Curr Osteoporos Rep. 2020 Jun;18(3):254-261. doi: 10.1007/s11914-020-00583-6. Curr Osteoporos Rep. 2020. PMID: 32222893 Free PMC article. Review.

3

Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation.

Courbon G, Thomas JJ, Martinez-Calle M, Wang X, Spindler J, Von Drasek J, Hunt-Tobey B, Mehta R, Isakova T, Chang W, Creemers JWM, Ji P, Martin A, David V. Courbon G, et al. Blood. 2023 Jul 6;142(1):106-118. doi: 10.1182/blood.2022018475. Blood. 2023. PMID: 37053547 Free PMC article.

4

Renal osteodystrophy: something old, something new, something needed.

David V, Salusky IB, Malluche H, Nickolas TL. David V, et al. Curr Opin Nephrol Hypertens. 2023 Nov 1;32(6):559-564. doi: 10.1097/MNH.0000000000000918. Epub 2023 Aug 8. Curr Opin Nephrol Hypertens. 2023. PMID: 37753646 Review.

5

Lipocalin-2: a novel link between the injured kidney and the bone.

Courbon G, David V. Courbon G, et al. Curr Opin Nephrol Hypertens. 2022 Jul 1;31(4):312-319. doi: 10.1097/MNH.0000000000000804. Curr Opin Nephrol Hypertens. 2022. PMID: 35727169 Free PMC article. Review.

6

FGF-23 and sclerostin in serum and bone of CKD patients.

Lima F, Monier-Faugere MC, Mawad H, David V, Malluche HH. Lima F, et al. Clin Nephrol. 2023 May;99(5):209-218. doi: 10.5414/CN111111. Clin Nephrol. 2023. PMID: 36970967 Free PMC article.

7

Inflammation regulates fibroblast growth factor 23 production.

Francis C, David V. Francis C, et al. Curr Opin Nephrol Hypertens. 2016 Jul;25(4):325-32. doi: 10.1097/MNH.0000000000000232. Curr Opin Nephrol Hypertens. 2016. PMID: 27191351 Free PMC article. Review.

8

Ironing out the cross talk between FGF23 and inflammation.

David V, Francis C, Babitt JL. David V, et al. Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F1-F8. doi: 10.1152/ajprenal.00359.2016. Epub 2016 Aug 31. Am J Physiol Renal Physiol. 2017. PMID: 27582104 Free PMC article. Review.

9

Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy.

Martinez-Calle M, Courbon G, Hunt-Tobey B, Francis C, Spindler J, Wang X, Dos Reis LM, Martins CS, Salusky IB, Malluche H, Nickolas TL, Moyses RM, Martin A, David V. Martinez-Calle M, et al. J Clin Invest. 2023 Jun 1;133(11):e159928. doi: 10.1172/JCI159928. J Clin Invest. 2023. PMID: 37079387 Free PMC article.

10

Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease.

Babitt JL, Sitara D. Babitt JL, et al. Curr Opin Nephrol Hypertens. 2019 Jul;28(4):304-310. doi: 10.1097/MNH.0000000000000514. Curr Opin Nephrol Hypertens. 2019. PMID: 31145704 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year